https://seekingalpha.com/news/4122202-insmed-sees-brensocatib-nda-bronchiectasis-q4?source=feed_sector_healthcare
Jul 03, 2024 - Insmed plans to submit New Drug Application for brensocatib to FDA for chronic lung condition in Q4 following positive phase 3 study results. Read more here.
0
sa:-6257268318065836258
0
https://www.zacks.com/stock/news/2296767/record-july-4-travel-may-see-stock-gains-for-skyw-rcl-hlt?cid=CS-ZC-FT-analyst_blog|investment_ideas-2296767
Jul 03, 2024 - A record number of Americans will travel this Independence Day, which bodes well for SkyWest (SKYW), Royal Caribbean Cruises (RCL) and Hilton Worldwide (HLT).
zc:3972312183351530919
0
https://www.cnbc.com/2024/07/03/student-loan-borrowers-in-save-plan-will-see-their-bill-lowered-in-july.html
Jul 03, 2024 - The Biden administration's new repayment plan for student loan borrowers is facing legal challenges. Here's what relief borrowers can still expect.
0
cnbc:-8907674144290594774
0
https://www.cnbc.com/2024/06/29/growth-value-stocks-could-see-boost-from-russell-rebalancing-.html
Jun 29, 2024 - This key market event could help boost growth and value stocks. Here’s why.
0
cnbc:-6691163636489785014
0
https://www.cnbc.com/2024/06/28/nike-ceo-john-donahoe-under-fire-from-wall-street.html
Jun 28, 2024 - Nike's CEO John Donahoe has helmed the sneaker giant for nearly five years, but under his watch, its stock has underperformed and its lost market share.
0
cnbc:2284710918526865356
0
https://seekingalpha.com/article/4701561-komatsu-i-like-what-i-see-with-key-businesses?source=feed_tag_japan
Jun 28, 2024 - Discover why Komatsu Ltd.'s aftermarket and mining equipment businesses are expected to drive revenue growth. Click for our updated look at KMTUF stock prospects.
0
sa:6549312044540903964
0
https://www.zacks.com/stock/news/2295035/wall-street-analysts-see-a-33-95-upside-in-gitlab-gtlb-can-the-stock-really-move-this-high?cid=CS-ZC-FT-tale_of_the_tape|consensus_price_target-2295035
Jun 28, 2024 - The average of price targets set by Wall Street analysts indicates a potential upside of 34% in Gitlab (GTLB). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
zc:623964498449163426
0
https://www.zacks.com/stock/news/2294929/wall-street-analysts-see-skechers-skx-as-a-buy-should-you-invest?cid=CS-ZC-FT-fundamental_analysis|average_broker_rating-2294929
Jun 28, 2024 - According to the average brokerage recommendation (ABR), one should invest in Skechers (SKX). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
zc:-1001174452575450148
0
https://seekingalpha.com/article/4701442-us-fund-flows-insight-report-equity-etfs-third-outflow-over-last-four-weeks?source=feed_tag_etf_portfolio_strategy
Jun 28, 2024 - During LSEG Lipper’s fund flows week that ended June 19, 2024, investors were overall net redeemers of fund assets for the first week in three, removing a net $30.0 billion.
0
sa:1366076394863231534
0
https://www.zacks.com/stock/news/2294367/wall-street-analysts-see-a-62-99-upside-in-xpeng-xpev-can-the-stock-really-move-this-high?cid=CS-ZC-FT-tale_of_the_tape|consensus_price_target-2294367
Jun 27, 2024 - The mean of analysts' price targets for XPeng (XPEV) points to a 63% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
zc:8150633202843289173
0